1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The joint pain injections market is experiencing significant transformation, propelled by the demand for minimally invasive therapies, innovation in biologics, and evolving clinical practice standards. Senior healthcare leaders navigating this market must understand the interplay of technology, regulation, and patient-focused care.
Market Snapshot: Joint Pain Injections Market Overview
The Joint Pain Injections Market grew from USD 5.04 billion in 2024 to USD 5.62 billion in 2025. It is expected to continue growing at a CAGR of 10.97%, reaching USD 9.43 billion by 2030.
Scope & Segmentation
- Molecule Types: Covers corticosteroids (betamethasone, methylprednisolone acetate, triamcinolone acetonide), hyaluronic acid (cross-linked, linear), and platelet-rich plasma (leukocyte-poor, leukocyte-rich).
- Indications: Focuses on gout (acute and chronic), osteoarthritis (knee, hip, shoulder), and rheumatoid arthritis (large joints, small joints).
- Routes of Administration: Details intra-articular (landmark-based, ultrasound-guided), intramuscular (deep tissue, superficial), and peri-articular (landmark-based, ultrasound-guided).
- End Users: Targets ambulatory surgical centers, hospitals, orthopedic clinics, and rheumatology clinics.
- Patient Age Groups: Analyzes specific needs for adolescents, adults, elderly, and pediatric populations.
- Regions: Examines key geographies across Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, the Middle East & Africa (including United Kingdom, Germany, France, United Arab Emirates, South Africa, and others), and Asia-Pacific (with China, India, Japan, Australia, South Korea, and additional markets).
- Technologies: Highlights ultrasound guidance, imaging analytics, and integration with digital health platforms.
- Major Companies: Profiles industry leaders such as Sanofi S.A., Ferring Pharmaceuticals A/S, Zimmer Biomet Holdings, Bioventus, Seikagaku Corporation, Anika Therapeutics, Fidia Farmaceutici, Merck, Johnson & Johnson, and AbbVie Inc.
Key Takeaways
- Advancements in imaging and ultrasound-guided injections are elevating procedural precision and reducing patient discomfort.
- Collaboration between industry and academic centers has accelerated the creation of novel injectables and personalized treatment protocols.
- Combinatorial use of corticosteroid derivatives and advanced adjuvants is enhancing and prolonging analgesic effects in joint pain therapies.
- Healthcare systems are increasingly embracing digital platforms for monitoring recovery and integrating patient feedback into ongoing clinical evaluations.
- Regional variations in reimbursement and regulatory approaches are influencing the adoption of both established and emerging therapies across markets.
- Segment-specific strategies are required as demand patterns differ distinctly by patient age, procedure type, and end-user environment.
Tariff Impact: Navigating U.S. Trade Policy Changes
New tariff structures in the United States are increasing raw material and finished product costs for joint pain injections and related devices. Manufacturers are adopting alternative sourcing and local production partnerships to offset elevated import duties. These shifts drive adjustments in pricing, procurement, and inventory management throughout the value chain.
Methodology & Data Sources
This market analysis relies on dual-track research: in-depth interviews with clinicians, procurement officers, and hospital administrators, complemented by a systematic review of published literature, peer-reviewed journals, and corporate filings. Analytical frameworks such as SWOT, Porter’s Five Forces, and scenario modeling were applied, with validation by expert panels.
Why This Report Matters
- Delivers actionable insights for optimizing clinical pathways, operational efficiency, and supply chain resilience amid regulatory and economic shifts.
- Guides strategic investments by aligning product development and commercial priorities with evolving patient and market demands.
- Empowers healthcare leaders to benchmark against competitors, capitalize on regional growth, and ensure evidence-based risk management.
Conclusion
This report equips stakeholders to make informed decisions in a rapidly evolving market. Aligning innovative therapeutic strategies with patient-centric approaches can unlock new value and advance care for joint pain patients globally.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of biologic-based viscosupplementation formulas targeting advanced osteoarthritis pain
5.2. Integration of platelet-rich plasma injections with personalized regenerative protocols for joint repair
5.3. Expansion of long-acting corticosteroid formulations reducing injection frequency and improving compliance
5.4. Growing investment in minimally invasive ultrasound-guided injection techniques for precise drug delivery
5.5. Emergence of combination therapies blending hyaluronic acid with stem cell components for enhanced efficacy
5.2. Integration of platelet-rich plasma injections with personalized regenerative protocols for joint repair
5.3. Expansion of long-acting corticosteroid formulations reducing injection frequency and improving compliance
5.4. Growing investment in minimally invasive ultrasound-guided injection techniques for precise drug delivery
5.5. Emergence of combination therapies blending hyaluronic acid with stem cell components for enhanced efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Joint Pain Injections Market, by Molecule Type
8.1. Introduction
8.2. Corticosteroids
8.2.1. Betamethasone
8.2.2. Methylprednisolone Acetate
8.2.3. Triamcinolone Acetonide
8.3. Hyaluronic Acid
8.3.1. Cross-Linked
8.3.2. Linear
8.4. Platelet-Rich Plasma
8.4.1. Leukocyte-Poor
8.4.2. Leukocyte-Rich
8.2. Corticosteroids
8.2.1. Betamethasone
8.2.2. Methylprednisolone Acetate
8.2.3. Triamcinolone Acetonide
8.3. Hyaluronic Acid
8.3.1. Cross-Linked
8.3.2. Linear
8.4. Platelet-Rich Plasma
8.4.1. Leukocyte-Poor
8.4.2. Leukocyte-Rich
9. Joint Pain Injections Market, by Indication
9.1. Introduction
9.2. Gout
9.2.1. Acute Management
9.2.2. Chronic Management
9.3. Osteoarthritis
9.3.1. Hip
9.3.2. Knee
9.3.3. Shoulder
9.4. Rheumatoid Arthritis
9.4.1. Large Joints
9.4.2. Small Joints
9.2. Gout
9.2.1. Acute Management
9.2.2. Chronic Management
9.3. Osteoarthritis
9.3.1. Hip
9.3.2. Knee
9.3.3. Shoulder
9.4. Rheumatoid Arthritis
9.4.1. Large Joints
9.4.2. Small Joints
10. Joint Pain Injections Market, by Route Of Administration
10.1. Introduction
10.2. Intra-Articular
10.2.1. Landmark-Based
10.2.2. Ultrasound-Guided
10.3. Intramuscular
10.3.1. Deep Tissue
10.3.2. Superficial
10.4. Peri-Articular
10.4.1. Landmark-Based
10.4.2. Ultrasound-Guided
10.2. Intra-Articular
10.2.1. Landmark-Based
10.2.2. Ultrasound-Guided
10.3. Intramuscular
10.3.1. Deep Tissue
10.3.2. Superficial
10.4. Peri-Articular
10.4.1. Landmark-Based
10.4.2. Ultrasound-Guided
11. Joint Pain Injections Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Orthopedic Clinics
11.5. Rheumatology Clinics
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Orthopedic Clinics
11.5. Rheumatology Clinics
12. Joint Pain Injections Market, by Patient Age Group
12.1. Introduction
12.2. Adolescents
12.3. Adults
12.4. Elderly
12.5. Pediatrics
12.2. Adolescents
12.3. Adults
12.4. Elderly
12.5. Pediatrics
13. Americas Joint Pain Injections Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Joint Pain Injections Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Joint Pain Injections Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Ferring Pharmaceuticals A/S
16.3.3. Zimmer Biomet Holdings, Inc.
16.3.4. Bioventus, Inc.
16.3.5. Seikagaku Corporation
16.3.6. Anika Therapeutics, Inc.
16.3.7. Fidia Farmaceutici S.p.A.
16.3.8. Merck & Co., Inc.
16.3.9. Johnson & Johnson
16.3.10. AbbVie Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Ferring Pharmaceuticals A/S
16.3.3. Zimmer Biomet Holdings, Inc.
16.3.4. Bioventus, Inc.
16.3.5. Seikagaku Corporation
16.3.6. Anika Therapeutics, Inc.
16.3.7. Fidia Farmaceutici S.p.A.
16.3.8. Merck & Co., Inc.
16.3.9. Johnson & Johnson
16.3.10. AbbVie Inc.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. JOINT PAIN INJECTIONS MARKET: RESEARCHAI
FIGURE 26. JOINT PAIN INJECTIONS MARKET: RESEARCHSTATISTICS
FIGURE 27. JOINT PAIN INJECTIONS MARKET: RESEARCHCONTACTS
FIGURE 28. JOINT PAIN INJECTIONS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. JOINT PAIN INJECTIONS MARKET: RESEARCHAI
FIGURE 26. JOINT PAIN INJECTIONS MARKET: RESEARCHSTATISTICS
FIGURE 27. JOINT PAIN INJECTIONS MARKET: RESEARCHCONTACTS
FIGURE 28. JOINT PAIN INJECTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. JOINT PAIN INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 174. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 175. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 176. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 177. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 178. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 179. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 182. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 183. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 184. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 185. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 186. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 187. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 190. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 191. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 192. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 193. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 194. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 195. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 204. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 205. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 206. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 207. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 210. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 211. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 218. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 219. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 220. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 221. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 222. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 223. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MIL
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 174. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 175. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 176. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 177. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 178. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 179. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 182. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 183. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 184. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 185. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 186. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 187. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 190. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 191. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 192. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 193. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 194. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 195. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 204. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 205. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 206. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 207. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 210. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 211. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 218. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 219. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 220. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 221. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 222. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 223. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2025-2030 (USD MIL
Samples
LOADING...
Companies Mentioned
- Sanofi S.A.
- Ferring Pharmaceuticals A/S
- Zimmer Biomet Holdings, Inc.
- Bioventus, Inc.
- Seikagaku Corporation
- Anika Therapeutics, Inc.
- Fidia Farmaceutici S.p.A.
- Merck & Co., Inc.
- Johnson & Johnson
- AbbVie Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 5.62 Billion |
| Forecasted Market Value ( USD | $ 9.43 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
